126 related articles for article (PubMed ID: 28120044)
21. Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): ultrastructural study.
Lewandowska E; Wierzba-Bobrowicz T; Rola R; Modzelewska J; Stepień T; Lugowska A; Pasennik E; Ryglewicz D
Folia Neuropathol; 2008; 46(2):123-33. PubMed ID: 18587706
[TBL] [Abstract][Full Text] [Related]
22. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment.
Gaeta M; Musumeci O; Mondello S; Ruggeri P; Montagnese F; Cucinotta M; Vinci S; Milardi D; Toscano A
Neuromuscul Disord; 2015 Nov; 25(11):852-8. PubMed ID: 26410244
[TBL] [Abstract][Full Text] [Related]
24. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease.
Laforêt P; Petiot P; Nicolino M; Orlikowski D; Caillaud C; Pellegrini N; Froissart R; Petitjean T; Maire I; Chabriat H; Hadrane L; Annane D; Eymard B
Neurology; 2008 May; 70(22):2063-6. PubMed ID: 18505979
[TBL] [Abstract][Full Text] [Related]
25. Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation.
Dubrovsky A; Corderi J; Lin M; Kishnani PS; Jones HN
Muscle Nerve; 2011 Dec; 44(6):897-901. PubMed ID: 21953123
[TBL] [Abstract][Full Text] [Related]
26. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
Malhotra K; Carrington DC; Liebeskind DS
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
[TBL] [Abstract][Full Text] [Related]
27. Pompe disease: An Indian series diagnosed on muscle biopsy by ultrastructural characterization.
Kakkar A; Sharma MC; Nambirajan A; Gulati S; Bhatia R; Suri V; Sarkar C
Ultrastruct Pathol; 2018; 42(3):211-219. PubMed ID: 29565761
[TBL] [Abstract][Full Text] [Related]
28. Screening for late-onset Pompe disease in western Denmark.
Hansen JS; Pedersen EG; Gaist D; Bach FW; Vilholm OJ; Sandal B; Weitemeyer L; Nielsen K; Schlesinger FE; Preisler N; Vissing J; Andersen H
Acta Neurol Scand; 2018 Jan; 137(1):85-90. PubMed ID: 28832912
[TBL] [Abstract][Full Text] [Related]
29. Screening for late-onset Pompe disease in Finland.
Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B
Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669
[TBL] [Abstract][Full Text] [Related]
30. Late form of Pompe disease with glycogen storage in peripheral nerves axons.
Fidziańska A; Ługowska A; Tylki-Szymańska A
J Neurol Sci; 2011 Feb; 301(1-2):59-62. PubMed ID: 21109266
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease.
Bertoldo F; Zappini F; Brigo M; Moggio M; Lucchini V; Angelini C; Semplicini C; Filosto M; Ravaglia S; Cotelli S; Todeschini A; Scarpelli M; Pancheri S; Tonin P
J Clin Endocrinol Metab; 2015 Feb; 100(2):401-6. PubMed ID: 25396301
[TBL] [Abstract][Full Text] [Related]
32. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.
Masat E; Laforêt P; De Antonio M; Corre G; Perniconi B; Taouagh N; Mariampillai K; Amelin D; Mauhin W; Hogrel JY; Caillaud C; Ronzitti G; Puzzo F; Kuranda K; Colella P; Mallone R; Benveniste O; Mingozzi F;
Sci Rep; 2016 Nov; 6():36182. PubMed ID: 27812025
[TBL] [Abstract][Full Text] [Related]
33. Are evoked potentials in patients with adult-onset pompe disease indicative of clinically relevant central nervous system involvement?
Wirsching A; Müller-Felber W; Schoser B
J Clin Neurophysiol; 2014 Aug; 31(4):362-6. PubMed ID: 25083849
[TBL] [Abstract][Full Text] [Related]
34. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease.
Van der Beek NA; Hagemans ML; Reuser AJ; Hop WC; Van der Ploeg AT; Van Doorn PA; Wokke JH
Neuromuscul Disord; 2009 Feb; 19(2):113-7. PubMed ID: 19084399
[TBL] [Abstract][Full Text] [Related]
35. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.
Horvath JJ; Austin SL; Case LE; Greene KB; Jones HN; Soher BJ; Kishnani PS; Bashir MR
Muscle Nerve; 2015 May; 51(5):722-30. PubMed ID: 25155446
[TBL] [Abstract][Full Text] [Related]
36. FDA approves new treatment for late-onset Pompe disease.
Home Healthc Nurse; 2010 Sep; 28(8):457. PubMed ID: 20811179
[No Abstract] [Full Text] [Related]
37. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
[TBL] [Abstract][Full Text] [Related]
38. The role of rehabilitation in the management of late-onset Pompe disease: a narrative review of the level of evidence.
Iolascon G; Vitacca M; Carraro E; Chisari C; Fiore P; Messina S; Mongini TEG; Sansone VA; Toscano A; Siciliano G
Acta Myol; 2018 Dec; 37(4):241-251. PubMed ID: 30944902
[TBL] [Abstract][Full Text] [Related]
39. Late-onset Pompe disease in a 54 year-old sportsman with an episode of syncope: a case report.
Walczak-Galezewska M; Skrypnik D; Szulinska M; Musialik K; Skrypnik K; Bogdanski P
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3665-3667. PubMed ID: 28925476
[TBL] [Abstract][Full Text] [Related]
40. 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry.
Scheidegger O; Leupold D; Sauter R; Findling O; Rösler KM; Hundsberger T
J Neurol; 2018 Dec; 265(12):2783-2788. PubMed ID: 30232608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
